Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
Bulletin Du Cancer|December 1, 1995
[Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)]P Brault, E Gilles, V Ribrag, et al.Oncology|November 1, 1993
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumorsJ L Pico, A Ibrahim, L Castagna, et al.Annales De Dermatologie Et De Venereologie|May 4, 2002
[Cutaneous localization of multiple myeloma on the tract of a central venous catheter]D Kerob, J M Vantelon, V Ribrag, et al.Neurology|December 13, 2006
Spectrum and prognosis of neurologic complications after hematopoietic transplantationC Denier, J-H Bourhis, C Lacroix, et al.Blood|November 15, 1994
Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantationT Petit, B Raynal, G Socié, et al.Leukemia & Lymphoma|October 21, 2003
Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin's lymphomasV Ribrag, S Koscielny, J M Vantelon, et al.Bone Marrow Transplantation|March 14, 2000
Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practiceJ M Vantelon, S Koscielny, P Brault, et al.Tissue Antigens|October 1, 1996
Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathwayB Bonnotte, C Pardoux, J H Bourhis, et al.Leukemia|January 13, 2006
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromesJ-J Kiladjian, E Bourgeois, I Lobe, et al.Oncogene|June 13, 2000
Altered natural killer cell differentiation in CD34+ progenitors from chronic myeloid leukemia patientsG Carayol, J Giron-Michel, B Azzarone, et al.Pageof 8